目的:研究重组人粒细胞刺激因子(Recombinant Human Granulocyte Colony-stimulating Factor,rhG-CSF)、重组人粒细胞巨噬细胞刺激因子(Recombinant Human Granulocyte/Macrophage Colony-stimulating Factor,rh GMCSF)对肿瘤患者化疗...目的:研究重组人粒细胞刺激因子(Recombinant Human Granulocyte Colony-stimulating Factor,rhG-CSF)、重组人粒细胞巨噬细胞刺激因子(Recombinant Human Granulocyte/Macrophage Colony-stimulating Factor,rh GMCSF)对肿瘤患者化疗后升白细胞、中性粒细胞疗效的差异。方法:回顾性分析86例肿瘤患者化疗后使用rhG-CSF、rhGM-CSF升白细胞、中性粒细胞治疗的情况。结果:43例患者经rhG-CSF治疗后白细胞、中性粒细胞升高有效率为90.7%,rhGM-CSF治疗43例患者白细胞升高有效率为74.4%,两组治疗差异具有统计学意义(P<0.05)。另外,rhG-CSF治疗后出现腹痛、腹泻、皮疹、肌肉骨骼疼痛、低血压、呼吸窘迫综合征等不良反应明显低于rhGM-CSF治疗组。结论:肿瘤患者化疗后rh G-CSF升高白细胞、中性粒细胞的疗效确切,不良反应小,值得推广应用。展开更多
目的建立注射用重组人粒细胞巨噬细胞刺激因子(Recombinant Human Granulocyte/Macrophage Colony-stimulating Factor for Injection,rhGM-CSF)药物利用评价标准,为临床合理应用rhGM-CSF提供参考。方法以rhGM-CSF药品说明书为基础,参...目的建立注射用重组人粒细胞巨噬细胞刺激因子(Recombinant Human Granulocyte/Macrophage Colony-stimulating Factor for Injection,rhGM-CSF)药物利用评价标准,为临床合理应用rhGM-CSF提供参考。方法以rhGM-CSF药品说明书为基础,参考相关指南和文献,并通过与临床专家讨论建立药物利用评价标准,采用回顾性调查方法,对漳州市某医院2019年6月~2022年6月使用rhGM-CSF的住院患者病历进行评价。结果共纳入157份病历,用药合理率为66.24%,不合理用药情况主要为给药剂量不适宜(13.38%)、给药时机不适宜(10.83%)、超说明书用药(7.01%)等方面。结论建立的rhGM-CSF药物利用评价标准有较强的科学性、实用性和可行性,在给药剂量、给药时机等管理方面可进一步优化。展开更多
目的:分析自体富血小板血浆(PRP)联合重组人粒细胞巨噬细胞集落刺激因子(rhGM-CSF)凝胶治疗下肢静脉性溃疡的临床效果。方法:选取2023年9月~2024年7月西京医院烧伤与皮肤外科门诊换药中心收治的90例下肢静脉性溃疡患者,采用随机数字表...目的:分析自体富血小板血浆(PRP)联合重组人粒细胞巨噬细胞集落刺激因子(rhGM-CSF)凝胶治疗下肢静脉性溃疡的临床效果。方法:选取2023年9月~2024年7月西京医院烧伤与皮肤外科门诊换药中心收治的90例下肢静脉性溃疡患者,采用随机数字表法分为对照组和研究组,每组各45例。对照组采取常规的rhGM-CSF凝胶换药治疗,研究组在对照组基础上联合使用PRP治疗,分析比较两组疗效。结果:研究组总有效率91.1%,明显高于对照组68.8% (P 2/w,较对照组0.26 ± 0.06 cm2/w快(P P P Objective: To analyze the clinical effect of autologous platelet-rich plasma (PRP) combined with recombinant human granulocyte macrophage colony-stimulating factor (rhGM-CSF) gel in the treatment of venous lower extremity ulcers. Methods: A total of 90 patients with venous lower extremity ulcers admitted to the Outpatient Dressing Center of the Department of Burn and Dermatology Surgery of Xijing Hospital from September 2023 to July 2024 were selected and randomly divided into a control group and a study group, with 45 cases in each group. The control group received conventional rhGM-CSF gel dressing treatment, and the study group used PRP treatment on the basis of the control group. The efficacy of the two groups was analyzed and compared. Results: The total effective rate of the study group was 91.1%, which was significantly higher than that of the control group (68.8%) (P 2/w, which was faster than that of the control group (0.26 ± 0.06 cm2/w) (P P P < 0.05). Conclusion: PRP combined with rhGM-CSF gel is effective in treating venous ulcers of lower extremities and can accelerate wound healing, which is worthy of clinical promotion.展开更多
文摘目的建立注射用重组人粒细胞巨噬细胞刺激因子(Recombinant Human Granulocyte/Macrophage Colony-stimulating Factor for Injection,rhGM-CSF)药物利用评价标准,为临床合理应用rhGM-CSF提供参考。方法以rhGM-CSF药品说明书为基础,参考相关指南和文献,并通过与临床专家讨论建立药物利用评价标准,采用回顾性调查方法,对漳州市某医院2019年6月~2022年6月使用rhGM-CSF的住院患者病历进行评价。结果共纳入157份病历,用药合理率为66.24%,不合理用药情况主要为给药剂量不适宜(13.38%)、给药时机不适宜(10.83%)、超说明书用药(7.01%)等方面。结论建立的rhGM-CSF药物利用评价标准有较强的科学性、实用性和可行性,在给药剂量、给药时机等管理方面可进一步优化。
文摘目的:分析自体富血小板血浆(PRP)联合重组人粒细胞巨噬细胞集落刺激因子(rhGM-CSF)凝胶治疗下肢静脉性溃疡的临床效果。方法:选取2023年9月~2024年7月西京医院烧伤与皮肤外科门诊换药中心收治的90例下肢静脉性溃疡患者,采用随机数字表法分为对照组和研究组,每组各45例。对照组采取常规的rhGM-CSF凝胶换药治疗,研究组在对照组基础上联合使用PRP治疗,分析比较两组疗效。结果:研究组总有效率91.1%,明显高于对照组68.8% (P 2/w,较对照组0.26 ± 0.06 cm2/w快(P P P Objective: To analyze the clinical effect of autologous platelet-rich plasma (PRP) combined with recombinant human granulocyte macrophage colony-stimulating factor (rhGM-CSF) gel in the treatment of venous lower extremity ulcers. Methods: A total of 90 patients with venous lower extremity ulcers admitted to the Outpatient Dressing Center of the Department of Burn and Dermatology Surgery of Xijing Hospital from September 2023 to July 2024 were selected and randomly divided into a control group and a study group, with 45 cases in each group. The control group received conventional rhGM-CSF gel dressing treatment, and the study group used PRP treatment on the basis of the control group. The efficacy of the two groups was analyzed and compared. Results: The total effective rate of the study group was 91.1%, which was significantly higher than that of the control group (68.8%) (P 2/w, which was faster than that of the control group (0.26 ± 0.06 cm2/w) (P P P < 0.05). Conclusion: PRP combined with rhGM-CSF gel is effective in treating venous ulcers of lower extremities and can accelerate wound healing, which is worthy of clinical promotion.
